Pfizer : PFE

All Pfizer Articles

1482 Articles

Jon C. Ogg | Jan 31, 2018 at 9:05 AM EST

Top Analyst Upgrades and Downgrades: AK Steel, Apple, Biogen, EA, FitBit, Foot Locker, McDonald’s, Pfizer and More

The top analyst upgrades, downgrades and other research calls from Wednesday include AK Steel, Apple, Biogen, Electronic Arts, FitBit, Foot…

Paul Ausick | Jan 30, 2018 at 4:01 PM EST

UnitedHealth, Pfizer Tank the DJIA Tuesday

UnitedHealth, Pfizer, McDonald's, and General Electric put in a dismal day and led the DJIA to steep loss Tuesday.

Paul Ausick | Jan 30, 2018 at 7:55 AM EST

Pfizer Earnings, Guidance May Not Be Enough for Investors

Pharmaceuticals giant Pfizer beat quarterly and full-year expectations this morning, but the beats were small and the forecast for next…

Chris Lange | Jan 28, 2018 at 10:20 AM EST

Apple, Boeing, Microsoft and More Dow Earnings Coming This Week

24/7 Wall St. has put together a preview of Exxon, Apple, Pfizer and other the Dow Jones Industrial Average companies…

Paul Ausick | Jan 26, 2018 at 4:01 PM EST

Intel, Pfizer Drive DJIA Surge Higher on Friday

Intel, Pfizer, 3M, and Disney launched the DJIA to a solid gain Friday.

Chris Lange | Jan 25, 2018 at 10:10 AM EST

Major Pharma Short Interest Keeps Climbing

The January 12 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Jan 17, 2018 at 4:15 PM EST

Beyond Apple Repatriation: 16 US Corporate Giants Have $1 Trillion in Cash

Apple indicated that it will pay $38 billion in repatriation taxes under the new tax law. Apple says that it…

Chris Lange | Jan 11, 2018 at 9:45 AM EST

Major Pharma Short Interest Takes a Plunge

The December 29 short interest data have been compared with the previous figures, and short interest in most of these…

Paul Ausick | Jan 8, 2018 at 4:01 PM EST

UnitedHealth, Disney Weigh on DJIA Monday

UnitedHealth, Disney, Pfizer, and General Electric were Monday's laggards among the DJIA stocks.

Chris Lange | Jan 4, 2018 at 9:10 AM EST

2018 Bull/Bear Outlook Pfizer and Merck: Where Does Major Health Care Go From Here?

For the Jones Industrial Average to make its 2018 targets, Pfizer and Merck will to have to do their part…

Chris Lange | Jan 3, 2018 at 10:45 AM EST

Sangamo Jumps on Newest Pfizer Collaboration

Sangamo Therapeutics shares made a handy gain on hump day after the firm announced that it would be collaborating with…

Jon C. Ogg | Jan 3, 2018 at 8:35 AM EST

2018 Bull/Bear Outlook: How All 30 DJIA Stocks Will Take the Market to 26,400 or Higher

Here is a consensus forecast of each of the 30 Dow Jones Industrial stocks, including a forward 12-month consensus analyst…

Chris Lange | Dec 28, 2017 at 10:25 AM EST

More and More Short Sellers Raising the Stakes in Major Pharma

The December 15 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical…

Jon C. Ogg | Dec 26, 2017 at 11:15 AM EST

Meet the Preliminary Dogs of the Dow for 2018

One strategy that has been popular each year as investors rebalance and make changes is the so-called Dogs of the…

Paul Ausick | Dec 20, 2017 at 4:01 PM EST

Disney, General Electric Hobble DJIA on Wednesday

Disney, Pfizer, General Electric, and McDonald's weighed on the DJIA Wednesday.

1 … 36 37 38 39 40 … 99

Pfizer : PFE

All Pfizer Articles

Top Analyst Upgrades and Downgrades: AK Steel, Apple, Biogen, EA, FitBit, Foot Locker, McDonald’s, Pfizer and More

UnitedHealth, Pfizer Tank the DJIA Tuesday

Pfizer Earnings, Guidance May Not Be Enough for Investors

Apple, Boeing, Microsoft and More Dow Earnings Coming This Week

Intel, Pfizer Drive DJIA Surge Higher on Friday

Major Pharma Short Interest Keeps Climbing

Beyond Apple Repatriation: 16 US Corporate Giants Have $1 Trillion in Cash

Major Pharma Short Interest Takes a Plunge

UnitedHealth, Disney Weigh on DJIA Monday

2018 Bull/Bear Outlook Pfizer and Merck: Where Does Major Health Care Go From Here?

Sangamo Jumps on Newest Pfizer Collaboration

2018 Bull/Bear Outlook: How All 30 DJIA Stocks Will Take the Market to 26,400 or Higher

More and More Short Sellers Raising the Stakes in Major Pharma

Meet the Preliminary Dogs of the Dow for 2018

Disney, General Electric Hobble DJIA on Wednesday

Why a $2.1 Million 401(k) Holder Is Moving From California to Nevada Before His First RMD at 73

Most Income Investors Have Never Heard of These 3 ETFs Paying Over 10 Percent Monthly

The Home Sale That Adds $5,880 a Year to a Retiree’s Medicare Premium Two Years Later

Why a $2.1 Million 401(k) Holder Is Moving From California to Nevada Before His First RMD at 73

The Home Sale That Adds $5,880 a Year to a Retiree's Medicare Premium Two Years Later

Why a $2.1 Million 401(k) Holder Is Moving From California to Nevada Before His First RMD at 73

Most Income Investors Have Never Heard of These 3 ETFs Paying Over 10 Percent Monthly

Pfizer : PFE

All Pfizer Articles

Top Analyst Upgrades and Downgrades: AK Steel, Apple, Biogen, EA, FitBit, Foot Locker, McDonald’s, Pfizer and More

UnitedHealth, Pfizer Tank the DJIA Tuesday

Pfizer Earnings, Guidance May Not Be Enough for Investors

Apple, Boeing, Microsoft and More Dow Earnings Coming This Week

Intel, Pfizer Drive DJIA Surge Higher on Friday

Major Pharma Short Interest Keeps Climbing

Beyond Apple Repatriation: 16 US Corporate Giants Have $1 Trillion in Cash

Major Pharma Short Interest Takes a Plunge

UnitedHealth, Disney Weigh on DJIA Monday

2018 Bull/Bear Outlook Pfizer and Merck: Where Does Major Health Care Go From Here?

Sangamo Jumps on Newest Pfizer Collaboration

2018 Bull/Bear Outlook: How All 30 DJIA Stocks Will Take the Market to 26,400 or Higher

More and More Short Sellers Raising the Stakes in Major Pharma

Meet the Preliminary Dogs of the Dow for 2018

Disney, General Electric Hobble DJIA on Wednesday

Why a $2.1 Million 401(k) Holder Is Moving From California to Nevada Before His First RMD at 73

Most Income Investors Have Never Heard of These 3 ETFs Paying Over 10 Percent Monthly

The Home Sale That Adds $5,880 a Year to a Retiree’s Medicare Premium Two Years Later

Featured Reads

Why a $2.1 Million 401(k) Holder Is Moving From California to Nevada Before His First RMD at 73

The Home Sale That Adds $5,880 a Year to a Retiree's Medicare Premium Two Years Later